|
MED20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.7327031182931E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.56789955755244E-10 |
| Normal-vs-Stage2 |
4.377300E-03 |
| Normal-vs-Stage3 |
4.08719946776159E-10 |
| Normal-vs-Stage4 |
1.66955338443131E-12 |
| Stage1-vs-Stage2 |
3.599600E-02 |
| Stage1-vs-Stage3 |
1.453570E-01 |
| Stage1-vs-Stage4 |
1.621630E-03 |
| Stage2-vs-Stage3 |
7.436100E-03 |
| Stage2-vs-Stage4 |
8.31990000000893E-05 |
| Stage3-vs-Stage4 |
5.372400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89970261743611E-11 |
| Normal-vs-AfricanAmerican |
1.417670E-04 |
| Normal-vs-Asian |
8.73619999675057E-08 |
| Caucasian-vs-AfricanAmerican |
5.100600E-01 |
| Caucasian-vs-Asian |
6.609800E-01 |
| AfricanAmerican-vs-Asian |
7.501600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84499999722476E-08 |
| Normal-vs-Female |
9.41324795888931E-12 |
| Male-vs-Female |
3.350200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.88989995769862E-09 |
| Normal-vs-Age(41-60Yrs) |
1.17689968881507E-10 |
| Normal-vs-Age(61-80Yrs) |
7.12320002982381E-09 |
| Normal-vs-Age(81-100Yrs) |
2.530300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.027000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.157600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.077400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.249200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.138400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.516200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.239100E-03 |
| Classical-VS-Follicular |
3.26890000001967E-06 |
| Classical-VS-Other |
7.094600E-01 |
| Classical-VS-Normal |
9.57400825285504E-12 |
| Tall-VS-Follicular |
3.08499999990275E-08 |
| Tall-VS-Other |
2.542400E-01 |
| Tall-VS-Normal |
4.83035833553913E-12 |
| Follicular-VS-Other |
2.881400E-01 |
| Follicular-VS-Normal |
6.397400E-03 |
| Other-VS-Normal |
1.450070E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.45769999959633E-07 |
| Normal-vs-N1 |
7.60724816473157E-13 |
| N0-vs-N1 |
4.426200E-04 |
|
|
